Overview of Therapeutic Drug Monitoring MarketThe Global Therapeutic Drug Monitoring Market is valued at USD 2.5 Billion in ...

A common asthma inhaler has been recalled in the UK due to a labelling error that could mislead patients about their dosage.

Astegolimab, an anti-ST2 monoclonal antibody designed to block signaling of IL-33 under development by Roche's (OTCQX:RHHBY) Genentech unit, failed to meet its primary endpoint in a phase 3 trial for ...

Tozorakimab, an anti-IL-33 antibody, improves lung function and may reduce exacerbations in high-risk COPD patients, early ...

Bronchodilator drugs such as salbutamol, a short acting β agonist, are widely prescribed for the symptomatic relief of breathlessness in COPD. 4 Unfortunately, not all patients benefit from ...

PEF failed to consistently reflect FEV1 improvements after bronchodilation, indicating that handheld spirometry may better ...

Kenvue, a consumer health company and makers of Benadryl cough syrup, on Friday announced the launch of 'Cough Clinics', an ...

Kenvue and API launch India's first Cough Clinics to improve cough diagnosis and treatment. The initiative aims to address ...

Asthma is an illness that commonly affects adults and children, and it serves as a common reason for children to attend emergency departments. An asthma exacerbation is characterised by acute or ...

A significant reduction was not observed in the annualised rate of moderate or severe COPD exacerbations with tezepelumab versus placebo. Further studies are required to evaluate the efficacy of ...

Jeremy Derozin is the fifth trainer from AQHA's Top 10 earnings list in 2024 to be sidelined for a positive test of the non-FDA approved bronchodilator ...